JNJ-54452840 Uses, Dosage, Side Effects and more
JNJ-54452840 is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies).
| Trade Name | JNJ-54452840 |
| Generic | Mibenratide |
| Mibenratide Other Names | JNJ-54452840, Mibenratide |
| Type | |
| Formula | C87H129N27O30S2 |
| Weight | Average: 2097.27 Monoisotopic: 2095.88400821 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
